📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
SBI Life Tax Demand Reduced by ₹4,846 Crore to ₹470.88 Crore Following Rectification
SBI Life Insurance has received a significant rectification order from the Income Tax Department for FY 2021-22, correcting a previously erroneous demand. The total tax and interest demand has been slashed from ₹5,317.18 crore to ₹470.88 crore after the company filed a rectification application highlighting calculation errors. This reduction of over 90% in the potential liability provides substantial financial relief. The company is continuing its appeal against the remaining demand before the Commissioner (Appeals).
Key Highlights
Total tax demand for FY 2021-22 reduced from ₹5,317.18 crore to ₹470.88 crore
Tax component specifically decreased from ₹4,286.63 crore to ₹315.84 crore
Interest component slashed from ₹1,030.55 crore to ₹155.04 crore
Rectification order issued under Section 154 of the Income Tax Act, 1961
Company maintains its appeal against the revised demand at the Commissioner Appeals level
💼 Action for Investors
This massive reduction in tax demand removes a significant financial overhang and is a major positive for the stock. Investors should continue to monitor the final resolution of the remaining ₹470.88 crore appeal.
SBI Life Seeks Approval for ₹70,900 Cr+ Related Party Transactions for FY 2026-27
SBI Life Insurance has issued a postal ballot notice seeking shareholder approval for material related party transactions (RPTs) for the upcoming financial year 2026-27. The company proposes transactions with State Bank of India (SBI) totaling ₹40,900 crore and with SBI DFHI Limited totaling ₹30,000 crore. These transactions primarily involve investment purchases and sales, premium income, and commission expenses conducted at arm's length. Shareholders can cast their votes via e-voting from March 1 to March 30, 2026.
Key Highlights
Proposed RPT with State Bank of India (SBI) capped at ₹40,900 crore for FY 2026-27.
Proposed RPT with SBI DFHI Limited capped at ₹30,000 crore for investment-related activities.
SBI transactions include ₹15,000 crore for investment purchases and ₹4,400 crore for commission expenses.
Premium income from SBI-related business is estimated at ₹6,000 crore for the fiscal year.
E-voting period is scheduled from March 1, 2026, to March 30, 2026, with results by April 2, 2026.
💼 Action for Investors
This is a routine regulatory requirement for listed companies to approve transactions with parent and group entities. Investors should note the scale of synergy with SBI, which remains a key driver for the company's distribution and investment strategy.
SBI Life Declares Interim Dividend of ₹2.70 Per Share for FY 2025-26
SBI Life Insurance has declared an interim dividend of ₹2.70 per equity share for the financial year 2025-26, which represents 27% of the face value. The company has established March 06, 2026, as the record date for determining shareholder eligibility, with the payout scheduled to be completed by March 27, 2026. Furthermore, the board is seeking shareholder approval via postal ballot for material related party transactions with State Bank of India and other group entities for the upcoming fiscal year 2026-27. This announcement underscores the company's consistent dividend policy and proactive regulatory planning for its bancassurance operations.
Key Highlights
Interim dividend of ₹2.70 per equity share declared for FY 2025-26
Record date for dividend entitlement is fixed as March 06, 2026
Dividend payment to be processed on or before March 27, 2026
Shareholder approval sought for material related party transactions with SBI and affiliates for FY 2026-27
Postal ballot e-voting period scheduled from March 01 to March 30, 2026
💼 Action for Investors
Investors interested in the dividend should ensure they hold the stock before the record date of March 06, 2026. The related party transactions are standard for SBI Life's business model and are unlikely to impact the stock's fundamental valuation.
SBI Life Declares Interim Dividend of ₹2.70 per Share for FY 2025-26
SBI Life Insurance Company has declared an interim dividend of ₹2.70 per equity share for the financial year 2025-26, representing a 27% payout on the face value of ₹10. The company has fixed March 06, 2026, as the record date for determining shareholder eligibility, with the payment scheduled to be completed by March 27, 2026. Furthermore, the board has initiated a postal ballot to seek approval for material related party transactions for FY 2026-27. These transactions involve major entities including State Bank of India and Yes Bank, which are critical to the company's bancassurance distribution model.
Key Highlights
Interim dividend of ₹2.70 per equity share (27% of face value) declared for FY 2025-26
Record date for dividend eligibility set for March 06, 2026
Dividend payout to shareholders to be completed on or before March 27, 2026
Shareholder approval sought for Material Related Party Transactions with SBI and Yes Bank for FY 2026-27
Postal ballot e-voting period scheduled from March 01 to March 30, 2026
💼 Action for Investors
Investors looking to benefit from the dividend should ensure they hold the stock before the ex-dividend date associated with the March 06 record date. The related party transaction approvals are routine for the company's business model and should be viewed as standard regulatory compliance.
SBI Life to Consider Interim Dividend on Feb 25; Record Date Set for March 06, 2026
SBI Life Insurance Company has scheduled a board meeting on February 25, 2026, to deliberate on the declaration of an interim dividend for the financial year 2025-26. The company has proactively fixed March 06, 2026, as the record date to identify eligible shareholders for the potential payout. In compliance with insider trading regulations, the trading window for designated persons is closed from February 21 to February 27, 2026. This move indicates the company's intent to distribute surplus cash to its shareholders.
Key Highlights
Board meeting scheduled for February 25, 2026, to consider interim dividend for FY 2025-26
Record date for dividend eligibility fixed as March 06, 2026
Trading window for insiders closed from February 21 to February 27, 2026
The dividend amount will be determined during the upcoming board meeting
💼 Action for Investors
Investors should watch for the dividend amount announcement on February 25 and ensure they hold shares before the ex-dividend date to qualify for the payout.
SBI Life Board to Consider Interim Dividend on Feb 25; Record Date Set for March 06
SBI Life Insurance Company Limited has scheduled a Board of Directors meeting on February 25, 2026, to consider and declare an interim dividend for the financial year 2025-26. The company has fixed March 06, 2026, as the record date for determining shareholder eligibility for the payout. In line with SEBI regulations, the trading window for designated persons is closed from February 21 to February 27, 2026. This announcement indicates a potential cash return to shareholders, pending board approval.
Key Highlights
Board meeting scheduled for February 25, 2026, to consider interim dividend for FY 2025-26.
Record date for determining dividend eligibility is fixed as March 06, 2026.
Trading window for insiders closed from February 21, 2026, to February 27, 2026.
The dividend declaration is subject to approval by the Board of Directors during the upcoming meeting.
💼 Action for Investors
Investors should watch for the dividend amount announcement on February 25 and ensure they hold the stock before the March 06 record date to be eligible for the payout.
SBI Life Receives Partial Relief in GST Case; Demand Reduced to ₹159.45 Crore
SBI Life Insurance has received an updated order from the GST appellate authority for FY 2018-19, providing partial relief. The total demand, which was previously ₹288.67 crore, has been reduced to ₹159.45 crore. This revised amount includes ₹63.36 crore in tax, ₹89.75 crore in interest, and ₹6.34 crore in penalty. The company has stated it will continue to contest the remaining demand by filing an appeal with the Appellate Tribunal.
Key Highlights
Total tax demand for FY 2018-19 reduced by approximately 45% to ₹159.45 crore
The original demand of ₹288.67 crore was first disclosed in April 2024
Key issues cited include ITC mismatches and non-reversal of credit on security transactions
SBI Life intends to file a further appeal against the partial demand upheld by the authority
💼 Action for Investors
Monitor the progress of the appeal in the Appellate Tribunal; while the reduction is positive, the remaining liability is still noteworthy.
SBI Life Q3 FY26: AUM Crosses ₹5 Trillion, VNB Grows 17% to ₹50.4 Billion
SBI Life reported a strong performance for Q3 FY26, with Assets Under Management (AUM) crossing the significant ₹5 trillion milestone. The Value of New Business (VNB) grew 17% YoY to ₹50.4 billion, while VNB margins improved to 27.2% despite regulatory headwinds. Although reported Profit After Tax (PAT) grew by only 4% to ₹16.7 billion due to GST and labor law impacts, the adjusted profit growth stood at a robust 34%. The company continues to lead the private market with a 23.5% share in New Business Premium.
Key Highlights
Assets Under Management (AUM) grew 16% YoY to reach ₹5.1 trillion.
Value of New Business (VNB) increased by 17% to ₹50.4 billion with a margin of 27.2%.
Individual Rated Premium (IRP) grew 15% to ₹166.8 billion, maintaining a 25.6% private market share.
Indian Embedded Value (IEV) stood at ₹801.3 billion, representing an 18% YoY growth.
Solvency ratio remains strong at 1.91, significantly above the regulatory requirement of 1.50.
💼 Action for Investors
Investors should take confidence in the company's ability to maintain margins and market leadership despite regulatory changes. The strong growth in Embedded Value and AUM suggests long-term value creation potential.
SBI Life 9M FY26 Results: VoNB Up 17% to ₹50.4 Billion, APE Grows 16%
SBI Life reported a steady performance for 9M FY26, with Annualized Premium Equivalent (APE) growing 16% YoY to ₹185.2 billion. The Value of New Business (VoNB) increased by 17% to ₹50.4 billion, supported by a slight expansion in margins to 27.2%. While Profit After Tax (PAT) saw a modest 4% growth to ₹16.7 billion, the Indian Embedded Value (IEV) rose significantly by 18% to ₹801.3 billion. The company maintained its private market leadership with a 25.6% share in Individual Rated Premium.
Key Highlights
Value of New Business (VoNB) grew 17% YoY to ₹50.4 billion with margins improving to 27.2%
Annualized Premium Equivalent (APE) reached ₹185.2 billion, marking a 16% YoY growth
Assets Under Management (AUM) crossed the ₹5.1 trillion mark, up 16% YoY
13th-month persistency improved by 101 bps to 87.1%, indicating better customer retention
Indian Embedded Value (IEV) stands at ₹801.3 billion, reflecting 18% YoY growth
💼 Action for Investors
Investors should focus on the strong growth in VoNB and IEV, which are key long-term value drivers for life insurers. While the cost ratio increased slightly to 11.2%, the company's market leadership and margin stability remain positive indicators.
SBI Life Q3 FY26 PAT Rises 4.7% YoY to ₹577 Cr; Gross Premium Up 22%
SBI Life reported a steady performance for Q3 FY26, with Gross Premium Income growing 21.8% year-on-year to ₹30,245 crore. Net profit saw a modest increase of 4.7%, reaching ₹577 crore compared to ₹551 crore in the same quarter last year. The company maintained a healthy solvency ratio of 1.91, well above the regulatory threshold of 1.50. While operating expenses increased, the 13th-month persistency ratio improved to 83.99%, indicating better customer retention.
Key Highlights
Gross Premium Income grew by 21.8% YoY to ₹30,245 crore in Q3 FY26.
Net Profit (PAT) increased by 4.7% YoY to ₹577 crore for the quarter.
Solvency ratio remains robust at 1.91, though down from 2.04 a year ago.
13th-month persistency ratio improved to 83.99% from 82.67% YoY.
Operating expense ratio increased to 11.56% compared to 9.67% in the previous year's quarter.
💼 Action for Investors
Investors should focus on the strong top-line growth and improving persistency, which are positive long-term indicators. The stock remains a solid play in the insurance sector, though rising expense ratios warrant monitoring.